Remi Health

What Remi Health does

Remi Health GmbH is a Berlin-based Diagnostics-as-a-Service platform founded in 2022 that provides a single API integration enabling healthcare companies to embed compliant, lab-grade diagnostic testing into their patient journeys. The platform consolidates what the company describes as five separate vendor functions — kit supply and logistics, decentralized sample collection, laboratory processing, medical oversight, and country-specific regulatory compliance — into one white-label, developer-facing product. Operationally it spans 10+ partner laboratories across Germany, Austria, Switzerland, and Spain with a portfolio of 150+ CE-marked tests and has processed over 1 million diagnostic tests since launch, supporting at-home (Tasso, Lancet, Evalyn Brush), phlebotomy, and on-site collection modalities.

The underlying technology is a REST API platform secured with OAuth2 and event-driven via signed webhooks, with core endpoints covering orders, phlebotomy, lab orders, and results delivery. Remi operates on EU-hosted, BSI C5-certified infrastructure with stated 100% GDPR compliance, and its partner labs meet ISO 15189, Rilibäk, CE-IVD, and MDR standards. The company sells exclusively B2B through direct enterprise sales (demo booking via Google Calendar) and a self-serve developer track, targeting four primary verticals: digital health platforms, longevity programs, clinical trials organizations, and insurance companies/payers, with insurance screening programs already covering approximately 5 million insured lives.

Revenue is generated through a combination of platform/SaaS integration fees (subscription/recurring), per-test transaction fees across its biomarker catalog, and custom enterprise partnership programs with payers structured as multi-year contracts. Pricing is opaque and quote-based with no publicly disclosed tiers. The company is privately held by co-founders and Co-CEOs Anthony Bielenstein and Marvin Abert, backed by €5M+ in total funding from IBB Ventures (lead seed investor), MSD Global Health Innovation Fund, Catalpa Ventures, and pre-seed angels as of early 2026, with capital earmarked for cross-border lab network and European geographic expansion toward a stated 2030 target of 100 million diagnostic tests processed annually.

Name

Remi Health

Legal name

Remi Health GmbH

Website

https://remihealth.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Short description

Remi Health is a Berlin-based Diagnostics-as-a-Service platform that provides a single API integration enabling healthcare companies to embed compliant lab-grade diagnostic testing across European markets, serving digital health platforms, longevity programs, clinical trials, and insurers.

Ownership category

akta.pro rank

Product category

Diagnostics-as-a-Service Platform

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Lab Data Exchange & Interoperability (HL7/FHIR/LDT Results Delivery) (HLACAMAL)

akta.pro secondary industry

Interoperability Standards, Profiles & Implementation (HL7/FHIR/IHE) (HLACABAA)

Keywords

• Clinical diagnostics platform
• Lab testing API
• Healthcare integration services
• Biomarker testing platform
• Diagnostic infrastructure software

Headquarters

HQ city

Berlin

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Platform/SaaS Integration Fees: B2B platform revenue from embedding diagnostics into partner products via API integration. Partners (health solutions, longevity companies, pharma, insurers) pay for access to the diagnostic infrastructure layer covering kits, logistics, lab execution, and result delivery.
2. Per-Test Transaction Fees: Revenue per diagnostic test processed through the platform, with tests covering 150+ biomarkers across CE-marked test portfolio. Volume scales with partner programs and insured lives covered.
3. Enterprise Partnership Programs: Custom programs for payers and insurers supporting screening programs (e.g., HPV, colorectal cancer) covering millions of insured lives, likely structured as multi-year contracts.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Remi Health operates a Diagnostics-as-a-Service platform that lets B2B partners embed compliant lab-grade diagnostic testing into their products through a single API integration. The platform unifies kit supply, logistics, decentralized sample collection (at-home, phlebotomy, partner sites), a multi-country European laboratory network, medical oversight, and GDPR-compliant digital result delivery behind white-label interfaces. Its portfolio spans 150+ CE-marked biomarker tests covering metabolic, hormonal, sexual health, nutritional, and cancer screening panels.

Product overview

Remi Health operates as a Diagnostics-as-a-Service platform offering a single unified integration to embed lab-grade diagnostics into patient journeys. The core platform combines a cross-border laboratory network (spanning Germany, Austria, Switzerland, Spain, and expanding), decentralized collection solutions (at-home, phlebotomy, on-site), digital ordering and logistics infrastructure, white-label API capabilities, secure digital result delivery, and medical guidance with EU regulatory compliance. The platform portfolio includes 150+ CE-Marked Tests across metabolic, hormonal, nutritional, sexual health, and cancer screening categories, 10+ partner labs, and supports 4-week time-to-launch. Health Solutions, Longevity, Clinical Trials, and Insurance Companies segments are served through the unified platform architecture.

Differentiator

Problem solved

Functional benefit

Products and services

• Remi Health Platform Unified Diagnostics-as-a-Service platform that lets B2B partners (digital health platforms, longevity programs, payers, and clinical trial sponsors) embed lab-grade diagnostics into their products via a single API. Covers test selection, kit supply, decentralized collection, multi-country lab processing, medical oversight, and GDPR-compliant digital result delivery across 150+ CE-marked biomarker panels.

Quantifiable outcome

• 1 million+ diagnostic tests processed since launch
• +4 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• MVZ ATOS Berlin GmbHcoreTechnology or IntegrationPartner laboratory (MVZ) processing diagnostic samples. Located at Stuttgarter Platz 1, 10627 Berlin. Selected and verified for compliance with data processing requirements under GDPR Art. 28.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Function Health: Function Health offers comprehensive at-home biomarker testing panels covering hormones, metabolic, and other markers. It is a peer in the white-label/diagnostic panel category, with shared B2B/enterprise potential and similar test catalog positioning.
• LetsGetChecked: LetsGetChecked offers at-home diagnostic testing with end-to-end lab connectivity and white-label/B2B partnerships. It is a direct peer given the shared at-home collection, partner lab model, and enterprise health partnerships, although LetsGetChecked also has a D2C channel.
• Health Gorilla: Health Gorilla operates a clinical network API for lab ordering, results delivery, and health data exchange in the US. Like Remi, it provides a single API integration consolidating fragmented lab and diagnostic data workflows, making it the closest direct peer in business model.
• Healthy.io: Healthy.io turns smartphone cameras into clinical-grade diagnostic tools with at-home testing kits and a partner network. It is comparable to Remi given its focus on decentralized diagnostics, multi-modal collection, and B2B partnerships with healthcare providers and insurers.

Broad incumbents

• Synlab: Synlab is Europe's largest medical diagnostics services provider with its own pan-European laboratory network. It is a broad incumbent comparable to Remi on the lab network side, although it operates labs directly rather than via an API-orchestration model.
• Medicover: Medicover is a European healthcare and diagnostics provider with integrated clinics and laboratory services across Central and Eastern Europe. It is a broad incumbent comparable to Remi on the pan-European diagnostics footprint and payer-aligned screening programs.
• Quest Diagnostics: Quest Diagnostics is a major US-headquartered clinical laboratory and diagnostics provider. It is a broad incumbent comparable to Remi on the lab services and B2B health platform dimensions, though its platform ambitions and European coverage are more limited.
• Eurofins Genomics: Eurofins is a global lab services and diagnostics group with strong European presence across clinical and specialty testing. It is a broad incumbent comparable to Remi as a backend lab, although it does not currently offer an embedded developer API platform.

Emerging players

• Imaware: Imaware provides at-home diagnostic testing with both consumer and B2B channels, with an emphasis on white-label enterprise offerings. It is a smaller emerging player overlapping with Remi in decentralized testing and enterprise integrations.
• Huma: Huma is a European digital health platform offering APIs and infrastructure for remote monitoring, decentralized trials, and digital health programs. It overlaps with Remi in serving clinical trials and payers with regulated health infrastructure across European markets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• TikToktiktok.com/@remihealth

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Remi Health